Immunis Funding & Investors
Irvine, CA
Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline.
immunisbiomedical.comTotal Amount Raised: $35,000,000
Immunis Funding Rounds
Series A
$25,000,000
Series A Investors
Ironwood VenturesBold Capital PartnersRemiges VenturesJLS FundLifespan Vision VenturesContinuum Health VenturesSeries A
$10,000,000
Series A Investors
Remiges VenturesContinuum Health Ventures
Funding info provided by Diffbot.